Letter to the Editor: Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment

被引：0
|
作者：
Liu, Qingran [1 ]
Li, Jinpeng [2 ]
Chen, Hua [2 ]
Song, Jinlong [2 ]
机构：
[1] Shandong First Med Univ, Binzhou Peoples Hosp, Dept Intervent Med, Binzhou, Shandong, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Intervent Therapy 1, Jinan 250117, Shandong, Peoples R China
来源：
HEPATOLOGY | 2025年 / 81卷 / 03期
关键词：
D O I：
10.1097/HEP.0000000000001215
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E101 / E102
页数：2
相关论文
共 50 条
  • [11] Double cancer of primary hepatic angiosarcoma and hepatocellular carcinoma treated with atezolizumab plus bevacizumab
    Yamauchi, Yurika
    Saeki, Issei
    Yamasaki, Takahiro
    Egusa, Maho
    Nishiyama, Natsuko
    Fujioka, Tsuyoshi
    Kawamoto, Daiki
    Nishimura, Tatsuro
    Tanabe, Norikazu
    Oono, Takashi
    Matsumoto, Toshihiko
    Ishikawa, Tsuyoshi
    Marumoto, Yoshio
    Matsukuma, Satoshi
    Shindo, Yoshitaro
    Tokumitsu, Yukio
    Yoshimine, Sota
    Murakami, Junichi
    Tanaka, Toshiki
    Kimura, Sotai
    Hoshii, Yoshinobu
    Hamano, Kimikazu
    Nagano, Hiroaki
    Takami, Taro
    HEPATOLOGY RESEARCH, 2023, 53 (07) : 681 - 686
  • [12] Treatment Outcomes and Toxicities for Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab
    Pakeerathan, Veenaa
    Babu, Hari
    Andelkovic, Vladimir
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 54 - 55
  • [13] Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
    Suzuki, Keito
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Matsumoto, Hiroaki
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada-Shimizu, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Asahina, Yasuhiro
    Okamoto, Ryuichi
    Kurosaki, Masayuki
    Izumi, Namiki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (06) : 1183 - 1189
  • [14] Prognostic significance of liver decompensation, liver function and portal hypertension in cirrhotic patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab
    Pallozzi, Maria
    Stella, Leonardo
    Cerrito, Lucia
    Santopaolo, Francesco
    Pompili, Maurizio
    Gasbarrini, Antonio
    Marra, Fabio
    Campani, Claudia
    Pellegrini, Elisa
    Tovoli, Francesco
    Piscaglia, Fabio
    Hollande, Clemence
    Sidali, Sabrina
    Bouattour, Mohamed
    Ponziani, Francesca Romana
    JOURNAL OF HEPATOLOGY, 2024, 80 : S452 - S453
  • [15] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
    Mathew Vithayathil
    Antonio D’Alessio
    Claudia Angela Maria Fulgenzi
    Naoshi Nishida
    Martin Schönlein
    Johann von Felden
    Kornelius Schulze
    Henning Wege
    Anwaar Saeed
    Brooke Wietharn
    Hannah Hildebrand
    Linda Wu
    Celina Ang
    Thomas U. Marron
    Arndt Weinmann
    Peter R. Galle
    Dominik Bettinger
    Bertram Bengsch
    Arndt Vogel
    Lorenz Balcar
    Bernhard Scheiner
    Pei-Chang Lee
    Yi-Hsiang Huang
    Suneetha Amara
    Mahvish Muzaffar
    Abdul Rafeh Naqash
    Antonella Cammarota
    Valentina Zanuso
    Tiziana Pressiani
    Matthias Pinter
    Alessio Cortellini
    Masatoshi Kudo
    Lorenza Rimassa
    David J. Pinato
    Rohini Sharma
    Hepatology International, 2023, 17 : 904 - 914
  • [16] Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma
    Cabibbo, Giuseppe
    Petta, Salvatore
    Barbara, Marco
    Attardo, Simona
    Bucci, Laura
    Farinati, Fabio
    Giannini, Edoardo G.
    Negrini, Giulia
    Ciccarese, Francesca
    Rapaccini, Gian Lodovico
    Di Marco, Maria
    Caturelli, Eugenio
    Zoli, Marco
    Borzio, Franco
    Sacco, Rodolfo
    Virdone, Roberto
    Marra, Fabio
    Mega, Andrea
    Morisco, Filomena
    Benvegnu, Luisa
    Gasbarrini, Antonio
    Svegliati-Baroni, Gianluca
    Foschi, Francesco Giuseppe
    Olivani, Andrea
    Masotto, Alberto
    Nardone, Gerardo
    Colecchia, Antonio
    Persico, Marcello
    Craxi, Antonio
    Trevisani, Franco
    Camma, Calogero
    JOURNAL OF HEPATOLOGY, 2017, 67 (01) : 65 - 71
  • [17] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
    Vithayathil, Mathew
    D'Alessio, Antonio
    Weinmann, Arndt
    Galle, Peter
    Fulgenzi, Claudia Angela Maria
    Fessas, Petros
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Muzaffar, Mahvish
    Amara, Suneetha
    Muhammed, Ambreen
    Naqash, Abdul Rafeh
    Personeni, Nicola
    Pressiani, Tiziana
    Cammarota, Antonella
    Pinter, Matthias
    Cortellini, Alessio
    Rimassa, Lorenza
    Pinato, David J.
    Sharma, Rohini
    JOURNAL OF HEPATOLOGY, 2022, 77 : S374 - S375
  • [18] Clinical impact on treatment effectiveness of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
    Suzuki, Keito
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Matsumoto, Hiroaki
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Kurosaki, Masayuki
    Izumi, Namiki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 479 - 479
  • [19] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
    Vithayathil, Mathew
    D'Alessio, Antonio
    Fulgenzi, Claudia Angela Maria
    Nishida, Naoshi
    Schoenlein, Martin
    von Felden, Johann
    Schulze, Kornelius
    Wege, Henning
    Saeed, Anwaar
    Wietharn, Brooke
    Hildebrand, Hannah
    Wu, Linda
    Ang, Celina
    Marron, Thomas U.
    Weinmann, Arndt
    Galle, Peter R.
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Lee, Pei-Chang
    Huang, Yi-Hsiang
    Amara, Suneetha
    Muzaffar, Mahvish
    Naqash, Abdul Rafeh
    Cammarota, Antonella
    Zanuso, Valentina
    Pressiani, Tiziana
    Pinter, Matthias
    Cortellini, Alessio
    Kudo, Masatoshi
    Rimassa, Lorenza
    Pinato, David J.
    Sharma, Rohini
    HEPATOLOGY INTERNATIONAL, 2023, 17 (04) : 904 - 914
  • [20] Serial Changes of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
    Murata, Yosuke
    Nosaka, Takuto
    Akazawa, Yu
    Tanaka, Tomoko
    Takahashi, Kazuto
    Naito, Tatsushi
    Matsuda, Hidetaka
    Ohtani, Masahiro
    Nakamoto, Yasunari
    CANCERS, 2024, 16 (13)
12345